| Size | Price | Stock | Qty |
|---|---|---|---|
| 10g |
|
||
| 25g |
|
||
| 50g |
|
||
| Other Sizes |
| Targets |
Tetraethylammonium nitrate does not have a defined pharmacological target as it is a chemical reagent. The compound is used in chemical processes including metal plating, electropolishing, metal reprocessing, phase transfer media, batteries, fuel cells, nanomaterials, industrial solvents, nuclear fuel reprocessing, enzymatic catalysis, and lubricants. Its primary applications are in industrial and research chemistry rather than as a therapeutic agent.
|
|---|---|
| ln Vitro |
No specific in vitro pharmacological activity data are available for tetraethylammonium nitrate as it is a chemical reagent. In research settings, the compound is used as a reagent for the preparation of nitronium triflate and in studies of luminescence. Its activity is assessed in terms of chemical reactivity and synthetic utility rather than direct biological activity.
|
| ln Vivo |
No specific in vivo pharmacological activity data have been documented for tetraethylammonium nitrate as it is not a therapeutic agent. The compound is used exclusively as a chemical reagent and industrial chemical. It is not administered to animals for pharmacological evaluation. Its applications are limited to chemical synthesis, materials science, and analytical chemistry laboratories.
|
| Enzyme Assay |
For non-cellular assays, tetraethylammonium nitrate is characterized by standard analytical techniques including NMR, HPLC, and titration to confirm identity and purity. The compound can be evaluated as a reagent in various chemical reactions including the preparation of nitronium triflate. Typical protocols involve dissolving the compound in appropriate solvents and analyzing reaction products by chromatographic methods. Purity is ≥98.0% by nonaqueous titration. The compound has a molecular weight of 192.26 and molecular formula C8H20N2O3.
|
| Cell Assay |
Tetraethylammonium nitrate is not used in cell-based assays as it is a chemical reagent. The compound is intended for synthetic chemistry and industrial applications. If handled in a biological laboratory context, appropriate safety precautions should be taken. The compound should be stored in a cool, dry place protected from light and moisture.
|
| Animal Protocol |
Tetraethylammonium nitrate is not used in animal studies as it is a chemical reagent. The compound is handled in chemistry laboratories with appropriate personal protective equipment. Storage: keep in a cool, dry place protected from light and moisture. The compound should be stored in a tightly sealed container.
|
| ADME/Pharmacokinetics |
Tetraethylammonium nitrate has a molecular weight of 192.26 and molecular formula C8H20N2O3. It appears as a white to almost white powder to crystal with a melting point of 282°C (dec.). Purity: ≥98.0% by nonaqueous titration. Storage: keep in a cool, dry place protected from light and moisture. The compound has an EINECS number of 217-725-5.
|
| Toxicity/Toxicokinetics |
Tetraethylammonium nitrate is for research use only and not for human consumption. Standard laboratory safety practices should be followed when handling this chemical. Nitrate salts should be handled with care and kept away from reducing agents and combustible materials. Appropriate personal protective equipment including gloves and safety glasses should be worn. Specific LD50 values and detailed toxicological profiles have not been extensively reported.
|
| Additional Infomation |
Tetraethylammonium nitrate (CAS 1941-26-0) is also known as tetraethylazanium nitrate, N,N,N-triethylethanaminium nitrate, and ammonium, tetraethyl-, nitrate. It has an EINECS number of 217-725-5 and PubChem CID of 74744. The compound is used in metal plating, electropolishing, phase transfer media, batteries, nanomaterials, and enzymatic catalysis. No clinical trials or therapeutic approvals exist.
|
| Molecular Formula |
C8H20N2O3
|
|---|---|
| Molecular Weight |
192.26
|
| Exact Mass |
192.147
|
| CAS # |
1941-26-0
|
| PubChem CID |
74744
|
| Appearance |
White to off-white solid powder
|
| Density |
1.029 g/mL at 25ºC
|
| Boiling Point |
>100ºC
|
| Melting Point |
-280ºC (dec.)
|
| Flash Point |
>100ºC
|
| Index of Refraction |
1.4450 (estimate)
|
| LogP |
2.166
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
4
|
| Heavy Atom Count |
13
|
| Complexity |
66.2
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
[O-][N+](=O)[O-].[N+](C([H])([H])C([H])([H])[H])(C([H])([H])C([H])([H])[H])(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H]
|
| InChi Key |
JTJKNAJRGLQKDZ-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C8H20N.NO3/c1-5-9(6-2,7-3)8-4;2-1(3)4/h5-8H2,1-4H3;/q+1;-1
|
| Chemical Name |
tetraethylazanium;nitrate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.2013 mL | 26.0064 mL | 52.0129 mL | |
| 5 mM | 1.0403 mL | 5.2013 mL | 10.4026 mL | |
| 10 mM | 0.5201 mL | 2.6006 mL | 5.2013 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
